Skip to content

Bruker BRKR Treasury stock, shares (in shares)

Treasury stock, shares (in shares) at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
IDEX logo
IDEXIEX
Mettler-Toledo International, Inc. logo
Mettler-Toledo International, Inc.MTD
Charles River Laboratories logo
Charles River LaboratoriesCRL
Abbott logo
AbbottABT

Other financials

Income statement

See full
Revenue$823.4M+2.7%
Gross profit$379.8M-2.9%
Operating income$10.2M-67.9%
Net income$14.4M-17.2%
EPS (diluted)$0.02-81.8%

Balance sheet

See full
Cash & equivalents$137.6M-26.7%
Total debt$1.7B-20.9%
Total equity$2.5B+34.6%
Total assets$6.1B+3.3%

Cash flow

See full
Operating cash flow$71.2M+9.5%
CapEx$24.2M-6.9%
Free cash flow$47.0M+20.5%

Valuation

See full
Market cap$8.71B-13.2%
Enterprise value$10.25B-14.9%
P/S2.5×-0.4×

Profitability

See full
Gross margin45.3%-3.7pp
Operating margin1.3%-5.0pp
Net margin-0.6%-10.0pp
FCF margin1.5%-3.6pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.7×-0.5×
Current ratio1.6×0.0×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:TreasuryStockCommonShares.

The official record: Bruker’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bruker's treasury stock, shares (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Bruker's treasury stock, shares (in shares)?
Bruker (BRKR) reported treasury stock, shares (in shares) of $30.9M in Q1 2026.
How has Bruker's treasury stock, shares (in shares) changed year-over-year?
Bruker's treasury stock, shares (in shares) decreased by 0.2% year-over-year, from $30.98M to $30.9M.
What is the long-term trend for Bruker's treasury stock, shares (in shares)?
Over 2 years (2022 to 2024), Bruker's treasury stock, shares (in shares) has grown at a 4.2% compound annual growth rate (CAGR), from $28.37M to $30.78M.